2009-11-16 06:49:20 - Altus Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/altus-pharma ..

Altus Pharmaceuticals Inc. (Altus) is a biopharmaceutical company focused on the development of oral and injectable protein therapeutics for gastrointestinal and metabolic disorders. The Company’s product candidates are based on its technology, which enables the crystallization of proteins for use as therapeutic drugs. The Company is developing its product candidate, ALTU-238, by applying crystallization technology. During the year ended December 31, 2008, Altus had crystallized more than 70 proteins for use in its research and development programs. More from Reuters »

Altus Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Altus Pharmaceuticals Inc. (Altus) is a biopharmaceutical company engaged in the development and commercialization of drugs for gastrointestinal and metabolic disorders. Altus develops orally-delivered

 

 

and injectable protein replacement products using its patented protein crystallization technology. Their products are used in the treatment of exocrine pancreatic insufficiency, growth hormone deficiency, hGH-related disorders, kidney stones, gout and phenylketonuria. The product line of the company includes Trizytek, ALTU-238, ALTU-237, ALTU-236 and ALTU-242. The company is headquartered in Massachusetts, United States.

The Altus Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.